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Disrupted epidermal differentiation characterizes
numerous diseases that impact >25% of the popula-
tion. In a search for dominant mediators of differ-
entiation, we defined a requirement for ZNF750 in
terminal epidermal differentiation. ZNF750 controlled
genes mutated in numerous human skin diseases,
including FLG, LOR, LCE3B, ALOXE3, and SPINK5.
ZNF750 induced progenitor differentiation via an
evolutionarily conserved C2H2 zinc finger motif.
The epidermal master regulator, p63, bound the
ZNF750 promoter and was necessary for its induc-
tion. ZNF750 restored differentiation to p63-deficient
tissue, suggesting that it acts downstream of p63. A
search for functionally important ZNF750 targets via
analysis of ZNF750-regulated genes identified KLF4,
a transcription factor that activates late epidermal
differentiation. ZNF750 binds to KLF4 at multiple
sites flanking the transcriptional start site and con-
trols its expression. ZNF750 thus directly links a
tissue-specifying factor, p63, to an effector of ter-
minal differentiation, KLF4, and represents a poten-
tial future target for disorders of this process.
INTRODUCTION
Transcription factors mediating somatic tissue development,
such as p63 in epidermis, can also act in homeostasis to enable
differentiation. In the case of epidermis, terminal differentiation
is essential for the acquisition of normal skin barrier function
and homeostasis, as demonstrated by both common and rare
human skin disorders, including atopic dermatitis, psoriasis,
ichthyosis vulgaris, and epidermal cancers, which in lifetime
aggregate afflict a large portion of the U.S. population (de Cid
et al., 2009; Leech and Moss, 2007; Nestle et al., 2009; Rogers
et al., 2010; Smith et al., 2006). Cells leaving the epidermal
progenitor layer first express early differentiation proteins, such
as keratins 1 and 10, and then, upon subsequently migrating to
outer epidermal layers, induce terminal differentiation proteins,
such as filaggrin, loricrin, and the late cornified envelope proteins
(LCEs). p63 is required both for the development (Mills et al.,Develo1999; Yang et al., 1999) and homeostasis of stratified epithelial
tissues. p63 acts in the latter setting to sustain stem cell func-
tion,(Senoo et al., 2007) to maintain stratified epithelial tis-
sue fate by preventing reversion to simple epithelium as well
as, paradoxically, to enable terminal differentiation (Truong and
Khavari, 2007; Truong et al., 2006). Several transcription factors,
including KLF4 (Patel et al., 2006; Segre et al., 1999), PRDM1/
Blimp1 (Magnu´sdo´ttir et al., 2007), and OVOL1 (Teng et al.,
2007) have been implicated in the induction of terminal differen-
tiation; however, the mechanisms controlling their expression
and how they are linked to p63 are unclear. Here, we demon-
strate that ZNF750 is a nuclear factor that is upregulated during
epidermal differentiation by p63. ZNF750 is necessary to turn on
the terminal epidermal differentiation gene program, which is
due in part to ZNF750 regulation of the differentiation specific
transcription factor KLF4.
RESULTS
Induction of ZNF750 Is Necessary for Terminal
Epidermal Differentiation
To identify potential effectors of terminal epidermal differenti-
ation, we searched for genes whose transcript levels were
temporally increased prior to this process. ZNF750, which
encodes a 723 amino acid protein of unknown function, was
increased >300-fold in epidermal cells by day 2 of differentiation
in calcium-containing media in vitro (Figures 1A–1C). In tissue,
ZNF750 protein was absent from the undifferentiated cell com-
partment adjacent to the basement membrane, but displayed
nuclear localization in spinous layer cells and above (Figure S1A
available online). ZNF750 is thus induced immediately prior to
engagement of the terminal differentiation gene expression
program. To test for a potential functional role for ZNF750 in
this setting, ZNF750 expression was depleted in regenerated
organotypic human epidermal tissue, a setting which recapitu-
lates the structure and differentiation gene expression program
of normal skin (Sen et al., 2010; Truong et al., 2006). Although
leaving early differentiation gene markers keratin 1 and 10 unaf-
fected (Figures S1B and S1C), ZNF750 loss abolished induction
of late differentiation genes, including FLG, LOR, LCE3A,
LCE3D, and SPRR1A (Figures 1D–1E). Loss of ZNF750 did not
result in increased apoptosis or affect the percentage of prolifer-
ative cells (Figures S1D–S1F). Although the percentage of prolif-
erative cells did not significantly change, there was an increased
number of proliferative cells in the normally differentiatedpmental Cell 22, 669–677, March 13, 2012 ª2012 Elsevier Inc. 669
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Figure 1. ZNF570 Is Required for Terminal Differentiation
(A) Differentiation gene induction heat map on day 3 of calcium treated keratinocytes (+Ca2+) to induce differentiation as compared to undifferentiated sub
confluent control keratinocytes (-Ca2+).
(B) ZNF750 mRNA induction during calcium-induced differentiation in vitro (ordinate is log10 scale). Data show standard error of the mean (SEM).
(C) ZNF750 protein induction during calcium-induced differentiation in vitro.
(D) Effects of siRNA-mediated ZNF750 depletion (ZNF750i) versus scrambled control (CTL) on terminal differentiation proteins in regenerated organotypic human
epidermal tissue; loricrin (LOR; green) and filaggrin (FLG; red), epidermal basement membrane is noted with dashed lines (scale bar = 25 mm).
(E) Terminal differentiation gene mRNA quantitation in epidermal tissue with two independent ZNF750 siRNAs versus scrambled control. Data show standard
error of the mean (SEM). N = 3. See also Figure S1.
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ZNF750 Controls Terminal Epidermal Differentiationsuprabasal layer suggesting that withdrawal from the cell
cycle did not properly occur in ZNF750i epidermis (Figures
S1E and S1G). ZNF750 is thus necessary for terminal epidermal
differentiation.
The Highly Conserved C2H2 Domain Is Necessary
for ZNF750 Function
Expression of ZNF750 in undifferentiated cells induced terminal
differentiation genes (Figure 2A), indicating that ZNF750 is not
only required for this process but is also sufficient to engage it.
Deletion analysis demonstrated that even partial ZNF750-driven
differentiation required amino-terminal but not carboxyl-terminal
ZNF750 sequences (Figure 2A). Loss of differentiation induction
ability of amino terminal mutants was not due to lack of expres-
sion since all mutants were comparably expressed (Figures S2A
and S2B). The amino terminal region of ZNF750 encompasses
an evolutionarily conserved block of 60 amino acids containing
a predicted C2H2 zinc finger sequence (Figure 2B). Point muta-
genesis of the C2H2 sequence abolished the capacity of ZNF750
to induce terminal differentiation despite being expressed to
wild-type levels (Figure 2C; Figure S2A). ZNF750 differentiation
effects thus depend upon a conserved amino terminal zinc finger
motif. Mutations in ZNF750 have also been linked to abnormal
terminal differentiation and enhanced keratinocyte proliferation
in a Jewish Moroccan family with seborrheic dermatitis-like and
psoriasiform elements (Birnbaum et al., 2006). This was found to670 Developmental Cell 22, 669–677, March 13, 2012 ª2012 Elsevierbe caused by a frameshift mutation in ZNF750 that results in
a truncated protein of 43 amino acids with only the first 19 amino
acids being identical to wild-type ZNF750. To determine if this
mutant, truncated ZNF750 (ZNF750 56_57 dupCC) is respon-
sible for abnormal proliferation and differentiation, the mutant
construct was generated and expressed in keratinocytes in-
duced to differentiate. Expression of ZNF750 56_57 dupCC did
not have any significant impacts on epidermal differentiation or
proliferation suggesting that the phenotype in patients may be
due to a haploinsufficiency of ZNF750 (Figures S2C and S2D).
p63 Is Necessary for ZNF750 Induction during
Differentiation
To study mechanisms of ZNF750 gene activation during epi-
dermal differentiation, we examined the promoter of ZNF750
for binding sites of transcription factors implicated in epidermal
gene regulation and found a region, highly conserved by
PhastCons, 500 bp upstream of the ZNF750 promoter (Fig-
ure S3A). This region also contains a sequence (Kouwenhoven
et al., 2010) matching the canonical p63 binding site (Figure 3A;
Figure S3A). p63, which regulates epidermal development, stem
cell function and differentiation (Crum and McKeon, 2010;
Koster, 2010; Truong and Khavari, 2007), is expressed in all living
layers of human epidermal tissue (http://www.proteinatlas.org;
Figure S3B), where it is required for induction of both early and
late epidermal differentiation genes (Truong et al., 2006). InInc.
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Figure 2. An Evolutionarily Conserved Amino Terminal C2H2 Zinc Finger Motif Is Required for ZNF750-Driven Terminal Differentiation
(A) Induction of terminal differentiation genes in undifferentiated sub confluent cells requires an intact ZNF750 amino terminus. Fold mRNA induction quantified
over undifferentiated control cells receiving vector control (CTL). Data show SEM, n = 3.
(B) A C2H2 sequence in the evolutionarily conserved ZNF750 amino terminus.
(C) C2H2 sequence requirement in ZNF750-driven differentiation. Differentiation gene expression is shown with expression of full-length ZNF750 with point
mutation in the amino-terminal C2H2 motif of either both cysteines (C2 Mut), both histidines (H2 Mut), all four residues (C2H2 Mut) or wild-type full-length control
in undifferentiated human keratinocytes.
Data show SEM, n = 3. See also Figure S2.
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Figure 3. ZNF750 Is a p63-Dependent Gene and Rescues Terminal Differentiation Gene Expression in p63-Deficient Tissue
(A) ZNF750 gene locus with canonical p63 binding sequence noted in the promoter 0.5 kb upstream of the transcriptional start site (TSS).
(B) p63 chromatin immunoprecipitation at the ZNF750 promoter in differentiated keratinocytes with p63 depletion [p63i] versus scrambled siRNA control [CTL] to
verify specificity. Data show mean with SEM.
(C) Reduction in ZNF750 mRNA with p63 depletion at day 3 of calcium-induced differentiation in vitro; siRNA to p63 (p63i) and scrambled siRNA control (CTL).
Data show SEM.
(D) Reduction in ZNF750 protein with p63 depletion.
(E) ZNF750 rescues loss of terminal differentiation gene expression due to p63 deficiency. mRNA quantification in tissue; p63i tissue is also depleted of p53 to
bypass the growth arrest that occurs with loss of p63 alone. Data show SEM.
(F) Protein expression in tissue quantified in (E). Note filaggrin protein expression in lower epidermis with ZNF750 (white arrowheads), scale bar = 30 mm. See also
Figure S3.
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ZNF750 Controls Terminal Epidermal Differentiationdifferentiated cells, chromatin immunoprecipitation (ChIP) using
a p63 antibody that recognizes all isoforms of p63 confirmed p63
binding to the putative p63 binding site in the ZNF750 promoter
but not to adjacent upstream and downstream sequences (Fig-
ure 3B). A recent ChIP-Seq study (Kouwenhoven et al., 2010)
on genome-wide p63 binding also shows enrichment of p63
binding 500 bp upstream of the promoter of ZNF750 (Fig-
ure S3A). Pan p63 depletion resulted in loss of p63 binding to
the ZNF750 promoter and diminished ZNF750 expression during672 Developmental Cell 22, 669–677, March 13, 2012 ª2012 Elsevierdifferentiation at both the mRNA and protein levels (Figures
3B–3D). To explore which isoform of p63 is responsible for
binding the ZNF750 promoter, ChIP was performed using a
TAp63 or p63a specific antibody. p63a was found to bind to
the ZNF750 promoter to the same levels as pan p63, whereas
no binding could be detected with the TAp63 antibody (Fig-
ure S3C). Knockdown of DNp63 using siRNAs targeting only
the DNp63 isoform confirmed the specificity of DNp63 binding
(Figure S3C). Taken together, these data suggest that DNp63a,Inc.
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ZNF750 Controls Terminal Epidermal Differentiationthe major p63 isoform expressed in epidermis, is also the major
p63 isoform that binds the ZNF750 gene.
To gain insight into how p63 controls ZNF750 expression,
ChIP was also performed on p63 in undifferentiated cells.
Surprisingly, p63 binds to the promoter of ZNF750 in the pres-
ence or absence of differentiation (Figure S3C). This suggests
that during differentiation p63 may interact with additional
proteins to alter the chromatin state. Supporting this, epigenetic
marks of active transcription (H3K4me3, H3K27ac, and RNA
Pol II) were only found on the promoter of ZNF750 in differen-
tiated cells whereas minimal binding was detected in undifferen-
tiated cells (Figure S3D). This RNA Pol II binding and incorpora-
tion of H3K4me3 and H3K27acmarks during differentiation were
dependant on p63 binding as knockdown of DNp63 prevents
incorporation of these marks of active transcription (Figure S3D).
To determine if the p63 binding site is necessary for activation
of ZNF750 during differentiation, the ZNF750 promoter region
containing the wild-type or mutated p63 binding site was cloned
into the pGreenFire luciferase reporter. In differentiated cells,
there was an induction of luciferase activity from the wild-
type ZNF750 promoter as compared to undifferentiated cells,
whereas there was no induction from the mutated promoter,
confirming that the p63 binding site is necessary for ZNF750
induction during differentiation (Figure S3E). Thus, p63 binds
directly to the ZNF750 promoter and is required for ZNF750
induction during differentiation.
Expression of ZNF750 Rescues Differentiation Loss Due
to p63 Depletion
While mediators of p63 effects on proliferation and adhesion
have been identified (Ihrie et al., 2005; Koster et al., 2007), effec-
tors of p63 differentiation impacts have yet to be fully defined. To
determine if ZNF750 could rescue differentiation loss due to
p63 depletion, we expressed ZNF750 in the setting of p63
knockdown; simultaneous tissue depletion of p53 was used, as
it has been previously confirmed to rescue proliferation and
stratification due to p63 loss without affecting differentiation
(Truong et al., 2006). ZNF750 restored terminal differentiation
gene induction to p63 depleted cells and tissue, even driving
differentiation gene expression ectopically into the normally
undifferentiated basal layer when it was expressed throughout
the epidermis (Figures 3E and 3F). These results also suggest
that the basal layer remains undifferentiated due to an absence
of ZNF750 since driving ZNF750 expression into the basal
layer results in premature terminal differentiation. Expression
of ZNF750 in the context of cultured p63 depleted cells placed
in differentiation also restored the expression of 71% (12/17) of
upregulated differentiation genes (Figure S3F). ZNF750 is there-
fore ap63-boundand regulated gene that can restore the expres-
sion of terminal differentiation genes in the setting of p63 loss.
ZNF750 Regulation of KLF4 Expression Mediates
Terminal Epidermal Differentiation
To identify potential effectors of ZNF750-mediated differentia-
tion, ZNF750 was depleted in primary keratinocytes placed
in differentiation conditions. 1,978 genes changed significantly
upon ZNF750 knockdown as compared to control cells during
differentiation (Figure 4A, yellow circle). To determine the num-
ber of genes regulated by ZNF750 that are differentiation regu-Develolated genes, the 1,978 genes were overlapped with the 3,138
genes that are differentially regulated during differentiation. A
significant fraction of the genes regulated by ZNF750 (878/
1,978) were differentiation genes (Figure 4A, overlap shown in
green). In epidermal keratinocytes, ZNF750 controlled a subset
of genes highly enriched for gene ontology terms related
to terminal epidermal differentiation (Figure 4A; Tables S1
and S2). Among ZNF750-dependent genes were both structural
and enzymatic genes implicated in terminal differentiation as
well as KLF4, which is a transcription factor that has been previ-
ously identified as a regulator of late differentiation (Segre et al.,
1999). Interestingly, a number of genes identified previously as
KLF4-dependent using KLF4 knockout and overexpression
mice (Patel et al., 2006), including ECM1, SPINK5, CDSN, FLG,
and LCE3 were also ZNF750 dependent. Genomic binding
sequences for KLF4, previously characterized by ChIP-seq
(Yang et al., 2008), were strongly enriched in the ZNF750-depen-
dent gene set (629 out of 1978 genes [31.8%] with an E-value =
1.1 3 10705), suggesting that ZNF750-regulated genes may
be controlled in part through KLF4 action (Figures 4B and 4C;
Table S3). Consistent with this, the gene expression sig-
nature of KLF4i and ZNF750i cells during differentiation strongly
overlapped with each other (p < 10300) (Figure 4D; Figure S4A;
Table S4), suggesting that ZNF750 regulated differentiation
genes may be mediated to a major degree through the actions
of KLF4.
To explore if ZNF750 may directly regulate the expression of
KLF4, ChIP was performed using a ZNF750 antibody in differen-
tiated cells to determine if ZNF750 bound to KLF4 either down-
stream or upstream from the transcriptional start site (TSS).
Binding was found at multiple sites flanking the TSS of KLF4,
which was abrogated by ZNF750 depletion (Figure 4E), whereas
no binding could be detected on the promoters of genes not
regulated by ZNF750 (Figure S4B). To determine if ZNF750
acts as an activator or repressor of KLF4, regions 0.78,
and +0.92 kb from the TSS of KLF4were cloned into the pGreen-
Fire luciferase reporter. Luciferase expression was assayed for
each reporter in both undifferentiated and differentiated cells.
There was a >3-fold activation of luciferase during differentiation
for the +0.92 kb reporter construct (Figure S4C, left). To
determine if this activation was a result of ZNF750 binding to
the +0.92 kb reporter construct, either wild-type or mutant
C2H2 ZNF750 was coexpressed with the reporter construct in
undifferentiated cells. Expression of wild-type but not C2H2
mutant ZNF750 resulted in activation of the reporter construct
(Figure S4C, right).
Further demonstrating that ZNF750 activates KLF4 ex-
pression, knockdown of ZNF750 during differentiation prevented
the induction of KLF4 gene expression, while enforced ex-
pression of wild-type but not the C2H2 ZNF750 mutant induced
expression of KLF4 in undifferentiated cells (Figures 4F and 4G).
Furthermore, enforced KLF4 expression partially rescued activa-
tion of ZNF750-dependent terminal differentiation genes in the
context of ZNF750 depletion (Figure S4D).
DISCUSSION
Here we report that ZNF750 is a differentiation p63 target gene
that promotes terminal epidermal differentiation. Induction ofpmental Cell 22, 669–677, March 13, 2012 ª2012 Elsevier Inc. 673
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Figure 4. ZNF750 Regulates KLF4 to Control Terminal Epidermal Differentiation
(A) Venn diagram (left) illustrating overlap between ZNF750-dependent genes and differentiation genes. The blue circle (Differentiation/ CTL: 3,304 genes)
represents all the genes that change significantly byR2-fold during epidermal differentiation. The yellow circle (Differentiation/ZNF750i: 1,978 genes) represents
the genes that change significantly R2-fold when ZNF750 is knocked down during differentiation compared to control differentiated cells. The overlap (878
genes; green) shows ZNF750-regulated epidermal differentiation genes. Heat map (middle) of the overlap showing epidermal differentiation regulated genes
affected by ZNF750 depletion during differentiation. CTL and ZNF750i represent heat maps generated from control and ZNF750i cells induced to differentiate.
Heat maps were normalized to undifferentiated control cells (red [induced] and blue [repressed]), log2 based scale. Gene Ontology terms (right) of ZNF750-
dependent genes (p values represent Bonferroni- corrected EASE score).
(B) Consensus mouse KLF4 binding motif (left) and consensus KLF4 binding motif (right) found informatically enriched in the promoter regions of ZNF750-
dependent genes.
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ZNF750 Controls Terminal Epidermal DifferentiationZNF750 expression is associated with DNp63a binding to the
promoter region of ZNF750 during differentiation and mutation
of the highly conserved p63 binding site prevents activation of
a ZNF750 promoter reporter construct. Interestingly, p63 binds
the promoter of ZNF750 in undifferentiated cells as well, sug-
gesting that additional factors may cooperate with p63 during
differentiation to turn on ZNF750 expression. p63 binding is
associated with deposition of transcriptionally active marks of
chromatin, such as H3K4me3 and H3K27 acetylation, as well
as RNA polymerase II loading onto the ZNF750 promoter. Loss
of p63 also prevents induction of ZNF750 expression during
differentiation. Enforced expression of ZNF750 can restore the
majority of p63 regulated differentiation genes studied that are
lost with p63 knockdown. p63 may also regulate other as of
yet unidentified factors to induce the differentiation program
since ectopic ZNF750 expression does not rescue all of p63
dependent differentiation genes.
The function of ZNF750 is to promote terminal epidermal
differentiation, as it is necessary for expression of late terminal
differentiation genes but not early ones. ZNF750 promotes differ-
entiation in part by inducing the expression of KLF4. ZNF750
binds multiple sites flanking the KLF4 TSS during epidermal
differentiation. Wild-type but not C2H2 mutant ZNF750 is both
necessary and sufficient for the induction of KLF4 expression.
KLF4 and ZNF750 also regulate a common set of genes (1,325
genes p value < 10300). ZNF750 may also regulate the terminal
differentiation program through regulating other transcription
factors or directly binding to differentiation genes. We present
a model where p63 induces ZNF750 as well as potentially
other factors during differentiation to engage the terminal
differentiation pathway. Then, ZNF750 can transcriptionally acti-
vate KLF4 to engage the terminal differentiation program
(Figure 4H).
Functionally, ZNF750 had been previously unstudied, yet the
only two prior publications to mention ZNF750 are consistent
with the potential clinical relevance for this model. The first-re-
ported single extended kindred with a ZNF750mutation resulted
in a truncated mutant protein of only 43 amino acids. The
patients manifested clinically as a dominant generalized skin
disease characterized by abnormal terminal epidermal dif-
ferentiation with cutaneous inflammation, and defined ZNF750
mRNA as being predominantly expressed in stratified epithelia
(Birnbaum et al., 2006). Expression of the 43 amino acid mutant
had no impacts on epidermal differentiation or proliferation in
our studies, suggesting that the phenotype may be due to a
haploinsufficiency of ZNF750. This is supported by another(C) 629 of the 1978 ZNF750 dependent genes contain consensus KLF4 binding
(D) Venn diagram illustrating overlap between changes identified with KLF4 and Z
These data were derived by first determining the significantly changed genes betw
them to the significantly changed genes between ZNF750i and control cells duri
(E) ChIP demonstrating ZNF750 binding to the regions of the KLF4 gene that fla
versus scrambled control (CTLi) knockdown represent specificity controls. Data
(F) ZNF750 depletion impairs KLF4 induction in differentiating epidermal cells. D
(G) Ectopic expression of full-length ZNF750 (ZNF750 FL), but not the C2H2 ZNF
cells. Data show SEM.
(H) Proposed model for epidermal differentiation. In this model, p63 induces the e
necessary for differentiation (dashed arrow). ZNF750 induces differentiation in pa
other factors necessary for differentiation (dashed arrows). KLF4 can directly bin
See also Figure S4.
Develofamilial genetic study that linked genetic mutations which re-
sulted in lower levels of ZNF750 to psoriasis (Yang et al.,
2008). ZNF750 thus connects the tissue-specifying factor p63
to the KLF4 transcription factor to enable terminal differentiation
and may provide a future potential target in human disorders of
this process.EXPERIMENTAL PROCEDURES
The Supplemental Experimental Procedures section, which includes list of
plasmids/retroviral constructs, siRNA, antibodies, and primer sequences, is
available online.
Tissue Culture
Primary human keratinocytes were derived from freshly isolated foreskin. Cells
were grown in KCSFM (GIBCO-BRL) supplemented with epidermal growth
factor and bovine pituitary extract. Cells were induced to differentiate by the
addition of 1.2 mM calcium for 1 through 4 days in full confluence. Amphotro-
phic phoenix cells were maintained in DMEM and 10% fetal bovine serum.
Retroviral Gene Transfer
Amphotrophic phoenix cells were transfected with 3 mg of each retroviral
expression construct. Transfections were done in 6-well plates using Lipofect-
amine 2000 (Invitrogen). Viral supernatants were collected 48 hr posttransfec-
tion and polybrene added (5 mg/ml). These supernatants were placed on
primary human keratinocytes and centrifuged for 1 hr. Cells were transduced
and selected using puromycin (2 mg/ml) after the last transduction.
Western Blotting and Immunofluorescence
Fifty micrograms of the cell lysates was used for immunoblotting and resolved
on 10% SDS-PAGE and transferred to PVDF membranes. Membranes were
incubated in primary and secondary for 1 hr each. For immunofluorescence
experiments, 7 mm thick epidermal sections from adult human skin or organo-
typic cultures were fixed in 4% paraformaldehyde for 15 min followed by
blocking in PBS with 2.5% normal goat serum, 0.3% Triton X-100, and 2%
bovine serum albumin for 30 min. Sections were incubated in primary anti-
bodies for 1 hr and secondary antibodies for another hour. TUNEL staining
was done with the TMR Red In Situ Cell Death Detection Kit from Roche.
Genetically Altered Regenerated Human Skin
For organotypic cultures, 1 million genetically modified keratinocytes were
seeded onto devitalized human dermis for 72 hr and then harvested for RNA
or protein expression.
Quantitative Reverse Transcriptase-PCR Analysis
Total RNA from cells was extracted using the Rneasy mini kit (QIAGEN) and
quantified by Nanodrop. One microgram of total RNA was reverse transcribed
using the 1st Strand cDNA Synthesis Kit for RT-PCR from Roche. Quantitative
PCR was performed using the Mx3000P (Stratagene) thermocycler. Samples
were run in triplicate and normalized to GAPDH.sites in their respective promoter regions.
NF750 depletion in primary keratinocytes induced to differentiate with calcium.
een KLF4i and control cells during differentiation (3,138 genes) and overlapping
ng differentiation (1,978 genes).
nk the transcription start site (TSS) in differentiating epidermal cells. ZNF750i
show mean with SEM.
ata show SEM.
750 mutant or lacZ control (CTL), induces KLF4 in undifferentiated epidermal
xpression of ZNF750 during differentiation (solid arrow) as well as other factors
rt by transcriptionally activating KLF4 (solid arrows). ZNF750 may also regulate
d to differentiation gene promoters to activate terminal differentiation genes.
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Microarray analysis was performed on biological duplicate samples. Labeling
of cDNA and hybridization to Affymetrix HG-U133 2.0 plus arrays were per-
formed at Stanford’s Pan facility. For gene expression analysis, arrays were
RMA normalized and differential expression was defined using the following
filters: Significance Analysis of Microarrays 3.0 with a false discovery rate
less than 5%, an average fold change R2 at any time point, and an average
raw expression intensity R100 at any time point. Hierarchical clustering and
heat map generation were performed using GeneSpring GX software (Agilent).
For future analyses, Affymetrix probe IDs were converted to unique Unigene
IDs. p values indicating the significance of the overlap between various gene
sets were calculated using Fisher’s exact test. GO term enrichment was per-
formed using DAVID with the total set of genes on the appropriate microarray
as the background, p values represent a Bonferroni-corrected modified
Fisher’s exact test.
siRNAs
All siRNAs used were generated from Dharmacon. The control siRNA
used is a nonfunctional oligo targeting p63 (Truong et al., 2006). siRNAs
targeting p63 were used as previously described (Truong et al., 2006).
siRNAs were generated against ZNF750 and KLF4. One nanomole of each
siRNAwas electroporated into 1million keratinocytes using Amaxa nucleofec-
tion reagents.
Reporter Assays
The lentiviral constructs for reporter assays were made by cloning promoter
regions of ZNF750 or KLF4 into pGreenFire (System Biosciences). 293T
cells were transfected with 11 mg of pGreenFire vector, 8.3 mg of pCMVD8.91
(gag/pol) and 2.8 mg pUC MD.G (VSVg envelope). Transfections were done in
a 10 cm dish with calcium phosphate (HBSS at pH 7.01). Virus supernatant
was collected 48 and 72 hr posttransfection and concentrated using Lenti-X
Concentrator (System Biosciences). Primary human keratinocytes were
transduced overnight with concentrated virus and selected with puromycin
(1 mg/ml). Firefly luciferase activity was measured using the Dual-luciferase
reporter assay system from Promega, on a TD-20/20 Luminometer (Turner
Designs) with a 10 s integration time. Luminescence was corrected for pro-
tein concentration and normalized to proviral integrants. Genomic DNA from
infected keratinocytes was isolated using QIAGEN DNeasy Blood & Tissue
Kit. Ten nanograms of genomic DNA was used for quantitative PCR using
ABI 7900HT. Samples were done in triplicate and normalized to PLAC2
promoter.
ChIP-Seq Analysis of p63 Binding to the Promoter of ZNF750
Raw sequencing reads were downloaded fromGEO data set GSE17611 (Kou-
wenhoven et al., 2010), mapped to hg18 and plotted in the UCSC genome
browser. The predicted p63 binding site from this study was utilized.
ACCESSION NUMBERS
Microarray data have been deposited into the GEO database with accession
number GSE32685.
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